{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:40:41Z","timestamp":1772577641159,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.joms.2011.02.093","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T15:50:35Z","timestamp":1311522635000},"page":"821-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Oral Bisphosphonate Use Increases the Risk for Inflammatory Jaw Disease: A Cohort Study"],"prefix":"10.1016","volume":"70","author":[{"given":"Peter","family":"Vestergaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Mosekilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else Marie","family":"Pinholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2011.02.093_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"Position paper on bisphosphonate-related osteonecrosis of the jaws: Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2011.02.093_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10006-009-0198-9","article-title":"Osteoradionecrosis of the jaws\u2014a current overview\u2014Part 1: Physiopathology and risk and predisposing factors","volume":"14","author":"Chrcanovic","year":"2010","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.joms.2006.02.011","article-title":"Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis?","volume":"64","author":"Zavras","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14219\/jada.archive.2008.0016","article-title":"Bisphosphonate use and the risk of adverse jaw outcomes: A medical claims study of 714,217 people","volume":"139","author":"Cartsos","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2011.02.093_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Ostonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib7","series-title":"Oral and Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws: History, Etiology, Prevention, and Treatment","author":"Marx","year":"2007"},{"key":"10.1016\/j.joms.2011.02.093_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaws and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2011.02.093_bib9","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2011.02.093_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2011.02.093_bib11","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1200\/jco.2006.24.18_suppl.8528","article-title":"Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy","volume":"24","author":"Hoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2011.02.093_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib13","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonates\u2013induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2011.02.093_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2011.02.093_bib16","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2011.02.093_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2011.02.093_bib18","first-page":"263","article-title":"The Danish National Hospital Register","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.joms.2011.02.093_bib19","first-page":"3741","article-title":"The Danish National Patient Register: Evaluation of data quality","volume":"157","author":"Mosbech","year":"1995","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.joms.2011.02.093_bib20","first-page":"287","article-title":"Osteoporosis and the risk of tooth loss","volume":"16","author":"Krall","year":"2006","journal-title":"Clin Calcium"},{"key":"10.1016\/j.joms.2011.02.093_bib21","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.1983.00350090044007","article-title":"Postmenopausal tooth loss","volume":"143","author":"Daniell","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.joms.2011.02.093_bib22","first-page":"17","article-title":"Postmenopausal estrogen replacement and tooth retention","volume":"22","author":"Krall","year":"1998","journal-title":"Compend Contin Educ Dent Suppl"},{"key":"10.1016\/j.joms.2011.02.093_bib23","first-page":"1001","article-title":"Osteoporosis: A review and its dental implications","volume":"23","author":"Mattson","year":"2002","journal-title":"Compend Contin Educ Dent"},{"key":"10.1016\/j.joms.2011.02.093_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1902\/jop.2005.76.1.11","article-title":"Longitudinal study of periodontal disease and edentulism with rates of bone loss in older women","volume":"76","author":"Famili","year":"2005","journal-title":"J Periodontol"},{"key":"10.1016\/j.joms.2011.02.093_bib25","first-page":"5","article-title":"The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial)","volume":"5","author":"El-Shinnawi","year":"2003","journal-title":"J Int Acad Periodontol"},{"key":"10.1016\/j.joms.2011.02.093_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1902\/jop.2005.76.7.1113","article-title":"Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study","volume":"76","author":"Lane","year":"2005","journal-title":"J Periodontol"},{"key":"10.1016\/j.joms.2011.02.093_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcms.2010.05.009","article-title":"Osteoporisis and bisphosphonate-related osteonecrosis of the jaw: Not just a sporadic coincidence\u2014A multi-centre study","volume":"39","author":"Otto","year":"2011","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239111003211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239111003211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:38:50Z","timestamp":1759509530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239111003211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0278239111003211"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2011.02.093","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Bisphosphonate Use Increases the Risk for Inflammatory Jaw Disease: A Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2011.02.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}